Stockreport

A Look at Invivyd (IVVD) Valuation After Advancing VBY329 RSV Antibody Candidate into Preclinical Development [Yahoo! Finance]

Invivyd, Inc.  (IVVD) 
PDF Invivyd (IVVD) recently captured attention with the nomination of its VBY329 monoclonal antibody candidate for preclinical development. The company aims to prevent RSV i [Read more]